YTA2

General Information


DRACP ID  DRACP05211

Peptide Name   YTA2

Sequence  YTAIAWVKAFIRKLRK

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  fluorescein

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H154N26O19

Absent amino acids  CDEGHMNPQS

Common amino acids  AK

Mass  223217

Pl  11.77

Basic residues  5

Acidic residues  0

Hydrophobic residues  9

Net charge  5

Boman Index  -1966

Hydrophobicity  10

Aliphatic Index  110

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  466

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16376307

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1531

DRACP is developed by Dr.Zheng's team.